Laser Isotope Separation Technologies Inc. (LIST) is proud to announce the successful closing of a funding round that raised $22 million, marking a significant milestone in the advancement of its groundbreaking laser technology. Based in the USA, LIST is the exclusive developer of a proprietary patented process that employs advanced infrared laser technology to selectively excite and separate isotopes with unparalleled efficiency. This innovative approach offers a myriad of applications, positioning LIST as the only USA-origin proprietary laser uranium enrichment company. The funds raised will be strategically allocated to further enhance the Laser Isotope Separation Technology (L.I.S.T), particularly in optimizing production for low-enriched uranium (LEU) and high-assay low-enriched uranium (HALEU) targeted for the next generation of nuclear reactors, including Small Modular Reactors and Microreactors. Additionally, the financing will support initiatives to produce stable isotopes crucial for medical and scientific research, along with applications in quantum computing and semiconductor manufacturing. With a world-class nuclear technical team and robust partnerships across government and private sectors, LIST is well-equipped to lead the charge in the evolving nuclear industry while offering a more energy-efficient alternative to traditional enrichment methods. This funding not only underscores investor confidence in LIST's vision but also paves the way for sustainable and innovative solutions in the nuclear sector. For more information about the cutting-edge work being done at LIST, please visit our website at LaserIsTech.com.
.png&w=3840&q=75)









.png&w=3840&q=75)


